Clinical trial
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage…
NCT00005840 · Gynecologic Oncology Group, Other · Completed
Key facts
| NCT number | NCT00005840 |
|---|---|
| Title | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer |
| Official title | Phase I Trial of the Treatment of Advanced Endometrial Cancer With Concurrent Weekly Paclitaxel and Cisplatin and Whole Abdominal Radiation Therapy |
| Lead sponsor | Gynecologic Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Stage III Uterine Corpus Cancer, Stage IV Uterine Corpus Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Paclitaxel, Cisplatin, Radiation Therapy |
| Enrollment | 35 |
| Start date | Jul 1, 2000 |
| Primary completion | Jul 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 31, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: